4
Changes in Ownership
CNS Pharmaceuticals, Inc. Filed Acc 0001683168-20-001966
Options or other derivatives
- Director acquired 46,559 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Evans Carl Anthony · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-06-12 | Grant or award : show line 1 in the form Option to purchase common stock | +46,559 | 146,559 | D |
Loading xslF345X03/ownership.xml…